StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
ARCHITORG.BO$51.11+1.77%
Fair $51.11+0.0%

ARCHITORG.BO

Archit Organosys Limited

Basic Materials / ChemicalsBSE

$51.11

+0.89 (+1.77%)

Fairly Valued+0.0%Fair Value $51.11Fund rank 32/100 · Data gapFallback financials|
SA 57/C
F-Score: 5/9

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 26% · confianza 25%

FCF escenarios

weak_data · normalized FCF $85.8M · quality 57.3/100

Data gap 32/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 46/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

57/100

C

Piotroski

5/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 0unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Sector-specific commodity mid-cycle model required: targets are disabled until normalized cycle price/cost-curve/reserve data exists.
Thesis & Journal · ARCHITORG.BOLocal privado en este navegador · Archit Organosys Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.0B

P/E

13.1x

↓

EV/EBITDA

6.7x

↓

ROE

10.5%

↑

Gross Margin

30.2%

↑

Debt/Equity

0.33

↑
52-Week Range$51
$34$58

TradingView lightweight chart

ARCHITORG.BO price, volumen y niveles de valoración

Último $51.11Periodo +93.8%
Fair value: $51.11

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

+5.2%

FCF CAGR

+5.7%

FCF margin

1.0%

FCF / Net income

0.18x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $1.41B · net income $80.3M · FCF $14.4M

2023-FY → 2026-FY

Gross margin

30.2%+6.6% pts

Operating margin

7.4%-4.8% pts

Net margin

5.7%-3.7% pts

FCF margin

1.0%+0.0% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$1.41B$1.41B$1.26B$1.10B$1.21B
Net Income$80.3M$80.3M$50.5M$33.4M$113.5M
EBITDA$193.0M$193.0M$160.6M$126.2M$224.0M
EPS——2.461.635.53
Gross Margin30.2%30.2%30.3%19.3%23.6%
Operating Margin7.4%7.4%5.6%1.3%12.2%
Net Margin5.7%5.7%4.0%3.0%9.4%
Balance Sheet
Debt/Equity0.330.330.400.410.51
Current Ratio1.411.41———
Cash Flow
Free Cash Flow$14.4M$14.4M$180.2M$85.8M$12.2M
Returns
ROE10.5%10.5%7.3%5.2%18.4%
Valuation
P/E13.0713.0718.0429.2811.88
EV/EBITDA6.676.677.399.557.20
P/B1.381.381.321.532.18
Growth & Yield
Revenue Growth12.2%12.2%13.8%-8.8%—
EPS Growth——50.9%-70.5%—
Dividend Yield1.0%1.0%———

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +11.2%

Total return

+11.2%

Start / end P/E

n/dx → n/dx

EPS bridge

2.46 → n/d

Residual

+10.2%

EPS growthn/d
Multiple reratingn/d
Dividend+1.0%
Residual / FX / buybacks / cross-term+10.2%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.